This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: The Innovations of Andreas Blum
Introduction
Andreas Blum is a notable inventor based in Bensheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment. His work exemplifies the intersection of science and innovation, showcasing how research can lead to potential breakthroughs in medicine.
Latest Patents
Andreas Blum holds a patent for "Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer." This patent includes compounds that can inhibit c-Kit kinase, which is crucial for the treatment of various cancer types. His innovative approach to drug development highlights the importance of targeted therapies in modern medicine. He has 1 patent to his name, reflecting his commitment to advancing healthcare solutions.
Career Highlights
Blum is currently employed at Merck Patent GmbH, where he continues to work on innovative pharmaceutical solutions. His role at Merck allows him to collaborate with other experts in the field, further enhancing his contributions to medical research. His dedication to improving patient outcomes through scientific innovation is evident in his work.
Collaborations
One of his notable coworkers is Dieter Dorsch, with whom he collaborates on various projects. Their partnership exemplifies the collaborative nature of scientific research, where shared expertise can lead to groundbreaking discoveries.
Conclusion
Andreas Blum's work in developing cancer treatment compounds demonstrates the vital role of inventors in advancing medical science. His contributions not only reflect his expertise but also the potential for innovation to change lives.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
